Solasta Ventures — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Chameleon Bioscienceschameleonbiosci.comMar 2021

BiotechBerkeley, US

Genine Winslow(Founder)inRan Geng(Director)Winnie Wan(Director)

Co-investorsBerkeley SkyDeck Fund Future Planet Capital Tachyon Ventures

Immunitas Therapeuticsimmunitastx.com inAug 2021

Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.

BiotechDigital HealthMedical DevicesWaltham, US

Amanda Wagner(CEO)inDan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)

BoardLaura Brass(Director)inKai Wucherpfennig(Director)

Co-investorsAgent Capital DC Investment Partners Lifelink Longwood Fund M Ventures Medical Excellence Capital +5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.